National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Respiratory tract infections (RTIs) are a major public health concern due to their high morbidity and mortality rates, and widespread distribution. Studies regarding the expert opinion on current practices, clinical observations, and experiences related to the use of oral antibiotics primarily, amoxicillin-clavulanate and cefuroxime for managing respiratory tract infections (RTIs) and otitis media in Indian settings were scarce. So, a cross-sectional, questionnaire based study was conducted to collect opinion among physicians involved in treating RTIs and otitis media across India between June 2022 and December 2022. It was observed that managing upper respiratory tract infections (URTI), majority of the experts (94.1%) preferred amoxicillin + clavulanic acid over other oral antibiotics, such as cefpodoxime, cefixime, azithromycin, cefuroxime, and cefuroxime + clavulanic acid. Furthermore, 91% of the experts opined that amoxicillin with clavulanic acid was better for URTI than other antibiotics and 88% of the respondents preferred to prescribe amoxicillin with clavulanic acid in managing acute otitis media. Additionally, majority of the clinicians (81%) reported that cefuroxime was the most commonly used oral antibiotic for managing lower respiratory tract infections (LRTIs). Nearly 62% of clinicians opined that cefuroxime has better tissue penetration compared to other broad-spectrum antibiotics. Thus, it was found that experts recommended a combination of amoxicillin with clavulanic acid and cefuroxime for the treatment of RTIs. Amoxicillin with clavulanic acid was the preferred choice for managing URTIs and acute otitis media in children, while cefuroxime was favored for lower LRTIs due to its superior tissue penetration and broad-spectrum antibiotic properties.
Adam, D., Scholz, H., Helmerking, M. 2000. Comparison of short-course (5 day) cefuroxime axetil with a standard 10-day oral penicillin V regimen in the treatment of tonsillopharyngitis. Journal of Antimicrobial Chemotherapy. 45(suppl_1):23–30. https://doi.org/10.1093/jac/45.suppl_1.23
Avendaño, C. L., Perret, P. C. 2020. Epidemiology of Respiratory Infections. Pediatric Respiratory Diseases. 263–72. https://doi.org/10.1007%2F978-3-030-26961-6_28
Badhwar, V., Ganapathy, S., Prabhudesai, P., Tulara, N., Varaiya, A., Vyas, D. 2016. A Relook of Cefuroxime in Community. An Option Still Beneficial. J Assoc Physicians India. 64(7):95-101.
Baillie, E. J., Merlo, G., Magin, P., Tapley, A., Mulquiney, K. J., Davis, J. S., et al., 2022. Antibiotic prescribing for upper respiratory tract infections and acute bronchitis: a longitudinal analysis of general practitioner trainees. Fam Pract. 39(6):1063–9. https://doi.org/10.1093/fampra/cmac052
Bax, R. P., Dawson, A. F., Mullinger, B. M., Dash, C. H. 1979. Cefuroxime in the treatment of lower respiratory tract infection. Curr Med Res Opin. 5(10):772–8. https://doi.org/10.1185/03007997909109012
Calderaro, A., Buttrini, M., Farina, B., Montecchini S, De Conto, F., Chezzi, C. 2022. Respiratory Tract Infections and Laboratory Diagnostic Methods: A Review with A Focus on Syndromic Panel-Based Assays. Microorganisms. 10(9):1856. https://doi.org/10.3390/microorganisms10091856
Calver, A. D., Walsh, N. S., Quinn, P. F., Baran, C., Lonergan, V., Singh, K. P., et al., 1997. Dosing of Amoxicillin/Clavulanate Given Every 12 Hours Is as Effective as Dosing Every 8 Hours for Treatment of Lower Respiratory Tract Infection. Clinical Infectious Diseases. 24(4):570–4. https://doi.org/10.1093/clind/24.4.570
Casey, J. R., Block, S., Hedrick, J., Almudevar, A., Pichichero, M. E. 2012. Comparison of Amoxicillin/Clavulanate High Dose to Cefdinir in Treatment of Acute Otitis Media. Drugs. 72(15):1991–7. https://doi.org/10.2165/11590320-000000000-00000
Chu, C. H., Wang, M. C., Lin, L. Y., Tu, T. Y., Huang, C. Y., Liao, W. H., et al., 2014. High-Dose Amoxicillin with Clavulanate for the Treatment of Acute Otitis Media in Children. The Scientific World Journal. 2014: e965096. https://doi.org/10.1155/2014/965096
Das, B., Sarkar, C., Majumder, A. G. 2006. Medication used for pediatric upper respiratory tract infections. Fundamental & Clinical Pharmacology. 20(4):385–90. https://doi.org/10.1111/j.1472-8206.2006.00414.x
Easton, J., Noble, S., Perry, C. M. 2003. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media. Drugs. 63(3):311–40. https://doi.org/10.2165/00003495-200363030-00005
Ferreira, J. B., Rapoport, P. B., Sakano, E., De Ávila Kós, A. O., Piltcher, O. B., Pignatari, S. N., et al., 2006. Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic Acid in the treatment of upper respiratory tract infections in adults - an open-label, multicentric, randomized trial. Brazilian Journal of Otorhinolaryngology. 72(1):104–11. https://doi.org/10.1016%2FS1808-8694(15)30041-0
Gessner, A., Klimek, L., Kuchar, E., Stelzmueller, I., Fal, A. M., Kardos, P. 2023. Potential Saving of Antibiotics for Respiratory Infections in Several European Countries: Insights from Market Research Data. Antibiotics. 12(7):1174. https://doi.org/10.3390/antibiotics12071174
Hoberman, A., Paradise, J. L., Rockette, H. E., Shaikh, N., Wald, E. R., Kearney, D. H., et al., 2011. Treatment of Acute Otitis Media in Children under 2 Years of Age. N Engl J Med. 364(2):105–15. https://doi.org/10.1056/nejmoa0912254
Hotwani, J. H., Tathe, A. V., Save, S. 2023. Drug utilization pattern in patients of upper respiratory tract infections in pediatrics outpatient department at a tertiary care hospital. International Journal of Basic & Clinical Pharmacology. 12(5):726–32. https://doi.org/10.18203/2319-2003.ijbcp20232571
Huang, G., Guo, F. 2022. Loss of life expectancy due to respiratory infectious diseases: findings from the global burden of disease study in 195 countries and territories 1990-2017. J Popul Res (Canberra). 39(1):1–43. https://doi.org/10.1007/s12546-021-09271-3
Joseph, N., Dr, B., B. S., Gr, N., George, N., M. S. 2016. Prescribing pattern of drugs in upper respiratory tract infections in pediatric outpatients. International Journal of Contemporary Pediatrics. 3(3):1006–8. https://doi.org/10.18203/2349-3291.ijcp20162381
Malo, S., Bjerrum, L., Feja, C., Lallana, M. J., Poncel, A., Rabanaque, M. J. 2015. Antibiotic prescribing in acute respiratory tract infections in general practice. Anales de Pediatría (English Edition). 82(6):412–6. https://doi.org/10.1016/j.anpede.2015.05.009
Mishra, S., Srivastava, P., Sunder, S., Mishra, A. K., Tanti, S. K. 2022. Evaluation and optimization of antibiotic usage in upper respiratory tract infections in children at a tertiary care outpatient department: A clinical audit. Indian J Pharmacol. 54(1):13–8. https://doi.org/10.4103/ijp.ijp_373_21
Pietrzykowska, M., Nowicka, S. K., Siebert, J. 2021. Respiratory tract infections in primary health care: prevalence and antibiotic prescribing in a primary care practice during one year. Family Medicine & Primary Care Review. 23(2):203–8. https://doi.org/10.5114/fmpcr.2021.105924
Samanta, T. C., Bax, R. P., Pearson, R. M., Havard, C. W., Brumfitt, W., Hamilton-Miller, J. M. 1980. Clinical study of cefuroxime in the treatment of lower respiratory tract infections. Curr Med Res Opin. 6(7):466–71. https://doi.org/10.1185/03007998009109469
Santoshi, K. M., Madhavi, J., Bala, K. N., Raja, M. K., Jyothy A. 2016. Prevalence and associated risk factors of otitis media and its subtypes in South Indian population. Egyptian Journal of Ear, Nose, Throat and Allied Sciences. 17(2):57–62. http://dx.doi.org/10.1016%2Fj.ejenta.2016.04.001
Sakulchit, T., Goldman, R. D. 2017. Antibiotic therapy for children with acute otitis media. Can Fam Physician. 63(9):685–7.
Tiwari, P., Ahlawat, R., Gupta, G. 2014. Prescription practice in patients of upper respiratory tract infection at a pediatric outpatient clinic in Punjab. IJOPP. 7(2):26–32. https://doi.org/10.5530/IJOPP.7.2.6
Veeraraghavan, B., Bakthavatchalam, Y. D., Sahni, R. D. 2021. Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy. Infectious Diseases and Therapy. 10(1):15. https://doi.org/10.1007/s40121-020-00374-7
Waghmode, R., Jadhav, S., Nema, V. 2021. The Burden of Respiratory Viruses and Their Prevalence in Different Geographical Regions of India: 1970–2020. Frontiers in Microbiology. 12:723850. https://doi.org/10.3389/fmicb.2021.723850
White, A. R., Kaye, C., Poupard, J., Pypstra, R., Woodnutt, G., Wynne, B. 2004. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J AntimicrobChemother. 53 Suppl 1: i3-20. https://doi.org/10.1093/jac/dkh050
Xuting, J., Jiajia, R., Ruohan, L., Ya, G., Haoying, Z., et al., 2023. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. eClinicalMedicine. 37: 100986. https://doi.org/10.1016/j.eclinm.2021.100986
Zulqarnain, M., Singh, S., Prasad, A., Abdullah, P. T. 2021. Use of Antibiotics in Upper Respiratory Tract Infections in Tertiary Care Teaching Hospital of Delhi. Journal of Drug Delivery and Therapeutics. 11(2-S):36–40. https://doi.org/10.22270/jddt.v11i2-S.4793
Citations |
 |
 |
 |
 |
